Literature DB >> 30881875

Diagnostic accuracy of 13N-ammonia myocardial perfusion imaging with PET-CT in the detection of coronary artery disease.

Ahmed Fathala1, Mervat Aboulkheir1,2, Mohamamed M Shoukri3, Hani Alsergani4.   

Abstract

BACKGROUND: 13N-ammonia positron emission tomography-computed tomography (PET-CT) is being increasingly used as a non-invasive imaging modality for evaluating patients with known or suspected coronary artery disease (CAD), but information about the diagnostic accuracy of PET-MPI is sparse.
Objectives: Our objective was to determine the accuracy of 13N-ammonia PET-CT myocardial perfusion imaging (MPI) for detecting CAD.
METHODS: We retrospectively evaluated 383 patients with suspected CAD who underwent rest-stress 13N- ammonia PET-CT MPI. Invasive coronary angiography (ICA) was performed within 60 days for all patients with abnormal PET-MPI findings and for selected patients with normal PET-MPI findings.
RESULTS: The mean age of the patients was 64±11 years, and the mean body mass index was 32±7 kg/m2. Stress perfusion defects were identified in 147 (34%) out of a total of 383 patients. ICA was performed in 213 patients (145 patients with abnormal PET and 68 patients with normal PET). The sensitivity of PET-MPI for detection of obstructive CAD based on ≥50% stenosis was 90%; specificity, 90%; positive predictive value, 96%; negative predictive value, 76%; and diagnostic accuracy, 80%.
CONCLUSIONS: PET-MPI with 13N-ammonia affords high sensitivity and overall accuracy for detecting CAD. The addition of coronary artery calcium score (CACS) can improve CAD risk stratification.

Entities:  

Keywords:  13N-ammonia positron emission tomography-computed tomography myocardial perfusion (13N-ammonia PET-CT myocardial perfusion); Positron emission tomography-computed tomography myocardial perfusion imaging (PETCT MPI); coronary artery calcium score (CACS)

Year:  2019        PMID: 30881875      PMCID: PMC6382649          DOI: 10.21037/cdt.2018.10.12

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  32 in total

1.  Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality.

Authors:  Leslee J Shaw; Paolo Raggi; Enrique Schisterman; Daniel S Berman; Tracy Q Callister
Journal:  Radiology       Date:  2003-07-17       Impact factor: 11.105

2.  CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner.

Authors:  Pascal Koepfli; Thomas F Hany; Christophe A Wyss; Mehdi Namdar; Cyrill Burger; Alexander V Konstantinidis; Thomas Berthold; Gustav K Von Schulthess; Philipp A Kaufmann
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

3.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

Review 4.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

5.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).

Authors:  Francis J Klocke; Michael G Baird; Beverly H Lorell; Timothy M Bateman; Joseph V Messer; Daniel S Berman; Patrick T O'Gara; Blase A Carabello; Richard O Russell; Manuel D Cerqueira; Martin G St John Sutton; Anthony N DeMaria; James E Udelson; J Ward Kennedy; Mario S Verani; Kim Allan Williams; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  Circulation       Date:  2003-09-16       Impact factor: 29.690

6.  Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project.

Authors:  Allen J Taylor; Jody Bindeman; Irwin Feuerstein; Felix Cao; Michael Brazaitis; Patrick G O'Malley
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

7.  Diagnosis of coronary artery disease using exercise echocardiography and positron emission tomography: comparison and analysis of discrepant results.

Authors:  T H Marwick; J J Nemec; W J Stewart; E E Salcedo
Journal:  J Am Soc Echocardiogr       Date:  1992 May-Jun       Impact factor: 5.251

Review 8.  Cardiac positron emission tomography imaging.

Authors:  Josef Machac
Journal:  Semin Nucl Med       Date:  2005-01       Impact factor: 4.446

9.  Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.

Authors:  Philip Greenland; Laurie LaBree; Stanley P Azen; Terence M Doherty; Robert C Detrano
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

10.  Detection of coronary artery disease with positron emission tomography and rubidium 82.

Authors:  M Grover-McKay; O Ratib; M Schwaiger; D Wohlgelernter; L Araujo; C Nienaber; M Phelps; H R Schelbert
Journal:  Am Heart J       Date:  1992-03       Impact factor: 4.749

View more
  3 in total

Review 1.  The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.

Authors:  Holis Abdul Holik; Faisal Maulana Ibrahim; Angela Alysia Elaine; Bernap Dwi Putra; Arifudin Achmad; Achmad Hussein Sundawa Kartamihardja
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

Review 2.  Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Authors:  George Crișan; Nastasia Sanda Moldovean-Cioroianu; Diana-Gabriela Timaru; Gabriel Andrieș; Călin Căinap; Vasile Chiș
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 3.  Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure.

Authors:  Viktoria Balogh; Mark G MacAskill; Patrick W F Hadoke; Gillian A Gray; Adriana A S Tavares
Journal:  Front Cardiovasc Med       Date:  2021-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.